IRIS
DI PINO, ANTONINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.079
EU - Europa 4.245
AS - Asia 3.715
SA - Sud America 745
AF - Africa 650
Continente sconosciuto - Info sul continente non disponibili 308
OC - Oceania 7
Totale 16.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.851
SG - Singapore 1.734
IT - Italia 1.572
RU - Federazione Russa 1.342
CN - Cina 807
BR - Brasile 619
IE - Irlanda 398
VN - Vietnam 368
CI - Costa d'Avorio 349
IN - India 210
FR - Francia 170
CA - Canada 149
SE - Svezia 147
BD - Bangladesh 142
KR - Corea 133
DE - Germania 117
GB - Regno Unito 113
UA - Ucraina 106
SN - Senegal 105
NG - Nigeria 93
HK - Hong Kong 53
TR - Turchia 53
NL - Olanda 49
FI - Finlandia 47
AR - Argentina 44
PL - Polonia 44
JP - Giappone 37
MX - Messico 36
ZA - Sudafrica 27
ES - Italia 26
IQ - Iraq 25
UZ - Uzbekistan 21
AT - Austria 20
BJ - Benin 20
EC - Ecuador 19
PK - Pakistan 19
MA - Marocco 17
CL - Cile 14
KE - Kenya 14
LT - Lituania 14
VE - Venezuela 13
CO - Colombia 12
LB - Libano 12
CH - Svizzera 11
GR - Grecia 11
JM - Giamaica 11
ID - Indonesia 10
IR - Iran 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
AU - Australia 7
IL - Israele 7
PA - Panama 7
SA - Arabia Saudita 7
BG - Bulgaria 6
BO - Bolivia 6
CR - Costa Rica 6
NP - Nepal 6
PH - Filippine 6
TN - Tunisia 6
ET - Etiopia 5
HR - Croazia 5
RO - Romania 5
TH - Thailandia 5
UY - Uruguay 5
AL - Albania 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MY - Malesia 4
OM - Oman 4
RS - Serbia 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
PE - Perù 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
GE - Georgia 2
IS - Islanda 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
MT - Malta 2
NO - Norvegia 2
PS - Palestinian Territory 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BM - Bermuda 1
Totale 16.420
Salva come PNG Salva come JPEG
Città #
Dallas 1.217
Singapore 1.081
Santa Clara 875
Chandler 611
Moscow 577
San Jose 543
Dublin 395
Ashburn 394
Abidjan 349
Chicago 298
Catania 285
Council Bluffs 205
Hefei 187
Beijing 182
Los Angeles 179
Boardman 167
Kochi 153
Civitanova Marche 146
Seoul 131
Jacksonville 128
Lauterbourg 125
Rome 113
Ho Chi Minh City 108
Cambridge 107
Dakar 105
Lawrence 102
Andover 101
New York 94
Hanoi 72
Houston 72
Wilmington 72
Dong Ket 67
Milan 67
Buffalo 60
Nanjing 58
Des Moines 57
São Paulo 55
Padova 54
Toronto 53
Palermo 48
Hong Kong 47
Abuja 43
Orem 42
Montreal 41
The Dalles 39
San Giovanni la Punta 37
Warsaw 36
Lagos 34
Tokyo 34
Boydton 32
Denver 32
Bremen 30
Columbus 28
Stockholm 27
Lappeenranta 26
Amsterdam 24
Brooklyn 24
Chennai 24
Munich 24
San Francisco 24
Belo Horizonte 23
Atlanta 20
Cotonou 20
Johannesburg 20
Ottawa 19
Seattle 19
Da Nang 18
London 18
Rosolini 18
Saint Petersburg 18
Carrara 17
Frankfurt am Main 17
Hebei 17
Naples 17
Rio de Janeiro 17
Phoenix 16
Poplar 16
Port Harcourt 16
Istanbul 15
Manchester 15
Boston 14
Charlotte 14
Messina 14
Shenyang 14
Brasília 13
Jiaxing 13
Washington 13
Ankara 12
Helsinki 12
San Mateo 12
Tashkent 12
Florence 11
Genoa 11
Nairobi 11
Figino 10
Nanchang 10
Shanghai 10
Bari 9
Enna 9
Guangzhou 9
Totale 10.930
Salva come PNG Salva come JPEG
Nome #
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 399
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 265
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 225
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 207
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 190
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 188
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 177
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 171
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 168
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 168
A multicenter prospective randomized controlled trial investigating the effects of combustion-free nicotine alternatives on cardiovascular risk factors and metabolic parameters in individuals with type 2 diabetes who smoke: the DiaSmokeFree study protocol 166
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 166
Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? 165
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 165
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 164
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. 164
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 164
Antibiotic use and associated factors in a large sample of hospitalised older people 163
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 156
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 155
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 153
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 151
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 151
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 150
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 148
A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin 148
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 148
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 147
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 147
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 146
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 146
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 146
Clinical and molecular biomarkers for diagnosis and staging of nafld 144
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 144
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 143
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 143
Heart failure and chronic kidney disease in a registry of internal medicine wards 141
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 140
Role of HbA1c in identify subjects with prediabetes and preclinical cardiovascular risk. 139
Smoking and diabetes: Dangerous liaisons and confusing relationships 139
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 139
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 138
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 137
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 135
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 134
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 134
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 134
Ultrasound in diagnosis of superior mesenteric artery syndrome 132
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 132
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 130
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 130
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 129
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 129
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 127
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 126
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. 125
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 125
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 124
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 123
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 123
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels 120
LONG NON-CODING RNA ASSOCIATI AL DIABETE MELLITO. FOCUS SULLE COMPLICANZE MICRO E MACROVASCOLARI 120
Correction: Smoking and diabetes: dangerous liaisons and confusing relationships 118
Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications 118
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 115
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications 114
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 114
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 113
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 113
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 113
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 112
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 110
Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects 107
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 107
Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice 106
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes 106
Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile 105
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects 104
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 103
Left ventricular geometry and periodontitis in patients with the metabolic syndrome 103
Ruolo dei linfociti FoxP3 nella infezione cronica da virus C. Risultati preliminari di un protocollo di studio clinico [Lymphocytes Fox P3 and chronic C hepatitis: preliminary results] 103
Triglycerides to high density lipoprotein cholesterol ratio (TG/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes 102
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience 101
Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c 99
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 99
Real-world efficacy of combination therapy with GLP1-RA and SGLT2-I in type 2 diabetes subjects with inadequate glucose control 98
L'emoglobina Glicosilata potrebbe identificare soggetti con normale tolleranza al glucosio ma con alterazione dei markers precoci di danno cardiovascolare. 98
Prediabete: Criteri diagnostici e rischio cardiovascolare 98
HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients 97
Progressive increases in adiposity and ectopic fat surrogates across glycaemic states highlight weight reduction as a key target for type 2 diabetes prevention, especially in younger people 95
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study 95
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People. 94
Impairment of Regenerative and Metabolic Pathways in Intestinal Organoids From Patients With MASLD-Cirrhosis 93
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 93
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 93
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity. 92
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study 91
What changed in the Italian internal medicine and geriatric wards during the lockdown 91
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units 91
Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis. 90
Totale 13.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.531
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022796 0 113 7 27 152 55 113 41 32 7 41 208
2022/20231.634 116 115 42 193 135 252 7 312 329 16 70 47
2023/2024917 37 169 48 28 50 189 27 112 16 29 125 87
2024/20253.599 67 484 197 310 679 456 178 114 171 297 431 215
2025/20268.106 426 409 1.444 603 1.116 1.550 841 148 412 482 345 330
2026/2027590 182 408 0 0 0 0 0 0 0 0 0 0
Totale 16.749